|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cliby WA, Powell MA, Alhammadi N, Chen L,
Miller JP, Roland PY, Mutch DG and Bristow RE: Ovarian cancer in
the United States: Contemporary patterns of care associated with
improved survival. Gynecol Oncol. 136:11–17. 2015. View Article : Google Scholar
|
|
3
|
Hausser J and Zavolan M: Identification
and consequences of miRNA-target interactions-beyond repression of
gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qin W, Xie W, He Q, Sun T, Meng C, Yang K,
Luo Y and Yang D: MicroRNA-152 inhibits ovarian cancer cell
proliferation and migration and may infer improved outcomes in
ovarian cancer through targeting FOXP1. Exp Ther Med. 15:1672–1679.
2018.PubMed/NCBI
|
|
5
|
Liu H, Pan Y, Han X, Liu J and Li R:
MicroRNA-216a promotes the metastasis and epithelial-mesenchymal
transition of ovarian cancer by suppressing the PTEN/AKT pathway.
Onco Targets Ther. 10:2701–2709. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neviani P and Fabbri M: Exosomic microRNAs
in the tumor microenvironment. Front Med. 2:472015. View Article : Google Scholar
|
|
7
|
Ying X, Wu Q, Wu X, Zhu Q and Wang X,
Jiang L, Chen X and Wang X: Epithelial ovarian cancer-secreted
exosomal miR-222-3p induces polarization of tumor-associated
macrophages. Oncotarget. 7:43076–43087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanlikilicer P, Rashed MH, Bayraktar R,
Mitra R, Ivan C, Aslan B, Zhang X, Filant J, Silva AM,
Rodriguez-Aguayo C, et al: Ubiquitous release of exosomal tumor
suppressor miR-6126 from ovarian cancer cells. Cancer Res.
76:7194–7207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De A, Powers B, De A, Zhou J, Sharma S,
Van VP, Bansal A, Sharma R and Sharma M: Emblica officinalis
extract downregulates pro-angiogenic molecules via upregulation of
cellular and exosomal miR-375 in human ovarian cancer cells.
Oncotarget. 7:31484–31500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng X, Müller V, Mildelangosch K,
Trillsch F, Pantel K and Schwarzenbach H: Diagnostic and prognostic
relevance of circulating exosomal miR-373, miR-200a, miR-200b and
miR-200c in patients with epithelial ovarian cancer. Oncotarget.
7:16923–16935. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin X, Yu S, Xu X, Bo S and Feng J:
Comparative analysis of microRNA expression profiles between A549,
A549/DDP and their respective exosomes. Oncotarget. 8:42125–42135.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smyth GK: Limma: Linear models for
microarray data. Bioinformatics and Computational Biology Solutions
using R and Bioconductor. Gentleman R, Carey V, Du S, Irizarry R
and Huber W: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar
|
|
13
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
14
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar
|
|
16
|
Therneau TM: A package for survival
analysis in S. R package version 2. 37:72014.
|
|
17
|
Shimizu Y, Kamoi S, Amada S, Akiyama F and
Silverberg SG: Toward the development of a universal grading system
for ovarian epithelial carcinoma: Testing of a proposed system in a
series of 461 patients with uniform treatment and follow-up.
Cancer. 82:893–901. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kosary CL: FIGO stage, histology,
histologic grade, age and race as prognostic factors in determining
survival for cancers of the female gynecological system: An
analysis of 1973-87 SEER cases of cancers of the endometrium,
cervix, ovary, vulva, and vagina. Semin Surg Oncol. 10:31–46. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar
|
|
20
|
Huang Da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davis AP, Grondin CJ, Johnson RJ, Sciaky
D, King BL, McMorran R, Wiegers J, Wiegers TC and Mattingly CJ: The
comparative toxicogenomics database: Update 2017. Nucleic Acids
Res. 45:D972–D978. 2017. View Article : Google Scholar :
|
|
22
|
Zhang Y, Wen X, Hu XL, Cheng LZ, Yu JY and
Wei ZB: Downregulation of miR-145-5p correlates with poor prognosis
in gastric cancer. Eur Rev Med Pharmacol Sci. 20:3026–3030.
2016.PubMed/NCBI
|
|
23
|
Ozen M, Karatas OF, Gulluoglu S, Bayrak
OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ
and Ittmann M: Overexpression of miR-145-5p inhibits proliferation
of prostate cancer cells and reduces SOX2 expression. Cancer
Invest. 33:251–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang Y, Yan W, Sun C, Liu Q, Wang J and
Wang M: miR-145-5p inhibits epithelial-mesenchymal transition via
the JNK signaling pathway by targeting MAP3K1 in non-small cell
lung cancer cells. Oncol Lett. 14:6923–6928. 2017.
|
|
25
|
Thuringer D, Jego G, Berthenet K, Hammann
A, Solary E and Garrido C: Gap junction-mediated transfer of
miR-145-5p from microvascular endothelial cells to colon cancer
cells inhibits angiogenesis. Oncotarget. 7:28160–28168. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong R, Liu X, Zhang Q, Jiang Z, Li Y, Wei
Y, Li Y, Yang Q, Liu J, Wei JJ, et al: miR-145 inhibits tumor
growth and metastasis by targeting metadherin in high-grade serous
ovarian carcinoma. Oncotarget. 5:10816–10829. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu H, Xiao ZH, Wang K, Liu W and Hao Q:
MiR-145 is down-regulated in human ovarian cancer and modulates
cell growth and invasion by targeting p70S6K1 and MUC1. Biochem
Biophys Res Commun. 441:693–700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto
T, Kato S and Miyazono K: Modulation of microRNA processing by p53.
Nature. 460:529–533. 2009. View Article : Google Scholar
|
|
29
|
Spizzo R, Nicoloso MS, Lupini L, Lu Y,
Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, et al:
miR-145 participates with TP53 in a death-promoting regulatory loop
and targets estrogen receptor-alpha in human breast cancer cells.
Cell Death Differ. 17:246–254. 2010. View Article : Google Scholar
|
|
30
|
Boominathan L: The guardians of the genome
(p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs
network. Cancer Metastasis Rev. 29:613–639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brachova P, Thiel KW and Leslie KK: The
consequence of oncomorphic TP53 mutations in ovarian cancer. Int J
Mol Sci. 14:19257–19275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han S, Belsare S, Zhang DY, Beveridge M,
Rinaldi C, Trevino JG, Schmittgen TD and Hughes SJ: Stroma-derived
extracellular vesicles deliver tumor-suppressive miRNAs to
pancreatic cancer cells. Oncotarget. 9:5764–5777. 2017.
|
|
33
|
Shi M, Jiang Y, Yang L, Yan S, Wang YG and
Lu XJ: Decreased levels of serum exosomal miR-638 predict poor
prognosis in hepatocellular carcinoma. J Cell Biochem.
119:4711–4716. 2018. View Article : Google Scholar
|
|
34
|
Zhang Z, Li X, Sun W, Yue S, Yang J, Li J,
Ma B, Wang J, Yang X, Pu M, et al: Loss of exosomal miR-320a from
cancer-associated fibroblasts contributes to HCC proliferation and
metastasis. Cancer Lett. 397:33–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Taylor DD 1 and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suetsugu A, Honma K, Saji S, Moriwaki H,
Ochiya T and Hoffman RM: Imaging exosome transfer from breast
cancer cells to stroma at metastatic sites in orthotopic nude-mouse
models. Adv Drug Deliv Rev. 5:383–390. 2013. View Article : Google Scholar
|
|
37
|
Ostenfeld MS, Jeppesen D, Morth JP, Khanh
HB, Dan T, Borre M, Dyrskjøt L and Ørntoft T: Abstract 3387:
Secreted exosomes from cultured bladder cells are enriched for
distinct miRNAs detected in circulation of metastatic bladder
cancer patients. Cancer Res. 72(Suppl): S33872012. View Article : Google Scholar
|
|
38
|
Hannafon BN, Trigoso YD, Calloway CL, Zhao
YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC and Ding WQ:
Plasma exosome microRNAs are indicative of breast cancer. Breast
Cancer Res. 18:902016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsushita R, Yoshino H, Enokida H, Goto
Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M and Seki N:
Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145
(miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell
aggressiveness. Oncotarget. 7:28460–28487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen X, Dong C, Law PT, Chan MT, Su Z,
Wang S, Wu WK and Xu H: MicroRNA-145 targets TRIM2 and exerts
tumor-suppressing functions in epithelial ovarian cancer. Gynecol
Oncol. 139:513–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim MJ, Gloss BS, Rajmohan M, Chang DK,
Colvin EK, Jones MD, Samuel Y, Howell VM, Brown LM, Wong CW, et al:
Connective tissue growth factor as a novel therapeutic target in
high grade serous ovarian cancer. Oncotarget. 6:44551–44562.
2015.
|
|
42
|
Kang W, Huang T, Zhou Y, Zhang J, Lung
RWM, Tong JHM, Chan AWH, Zhang B, Wong CC, Wu F, et al: miR-375 is
involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in
gastric carcinogenesis. Cell Death Dis. 9:n922018. View Article : Google Scholar
|
|
43
|
Pobbati AV and Hong W: Emerging roles of
TEAD transcription factors and its coactivators in cancers. Cancer
Biol Ther. 14:390–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tan G, Cao X, Dai Q, Zhang B, Huang J,
Xiong S, Zhang Y, Chen W, Yang J and Li H: A novel role for
microRNA-129-5p in inhibiting ovarian cancer cell proliferation and
survival via direct suppression of transcriptional co-activators
YAP and TAZ. Oncotarget. 6:8676–8686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han Q, Zhang HY, Zhong BL, Wang XJ, Zhang
B and Chen H: MicroRNA-145 inhibits cell migration and invasion and
regulates epithelial-mesenchymal transition (EMT) by targeting
connective tissue growth factor (CTGF) in esophageal squamous cell
carcinoma. Med Sci Monit. 22:3925–3934. 2016. View Article : Google Scholar :
|
|
46
|
Lee HK, Bier A, Cazacu S, Finniss S, Xiang
C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Squadrito ML, Baer C, Burdet F, Maderna C,
Gilfillan G, Lyle R, Ibberson M and De Palma M: Endogenous RNAs
modulate microRNA sorting to exosomes and transfer to acceptor
cells. Cell Rep. 8:1432–1446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li L, Li C, Wang S, Wang Z, Jiang J, Wang
W, Li X, Chen J, Liu K, Li C and Zhu G: Exosomes derived from
hypoxic oral squamous cell carcinoma cells deliver miR-21 to
normoxic cells to elicit a prometastatic phenotype. Cancer Res.
76:1770–1780. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fang T, Lv H, Lv G, Li T, Wang C, Han Q,
Yu L, Su B, Guo L, Huang S, et al: Tumor-derived exosomal
miR-1247-3p induces cancer-associated fibroblast activation to
foster lung metastasis of liver cancer. Nat Commun. 9:1912018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Trivedi M, Talekar M, Shah P, Ouyang Q and
Amiji M: Modification of tumor cell exosome content by transfection
with wt-p53 and microRNA-125b expressing plasmid DNA and its effect
on macrophage polarization. Oncogenesis. 5:e2502016. View Article : Google Scholar : PubMed/NCBI
|
